Daré Bioscience, Inc.DARENASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-70.8%
5Y CAGR-60.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-70.8%/yr
vs -1.0%/yr prior
5Y CAGR
-60.0%/yr
Recent deceleration
Acceleration
-69.8pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $279354.00 | -96.9% |
| 2024 | $9.16M | -24.4% |
| 2023 | $12.11M | +7.7% |
| 2022 | $11.24M | -71.1% |
| 2021 | $38.97M | +42.6% |
| 2020 | $27.32M | +90.6% |
| 2019 | $14.33M | +22.6% |
| 2018 | $11.70M | +216.9% |
| 2017 | $3.69M | -90.3% |
| 2016 | $37.92M | - |